Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial

Etude concernée: IFCT-0703
Auteurs / Authors: Besse B, Mazières J, Ribassin-Majed L, Barlesi F, Bennouna J, Gervais R, Moreau L, Berard H, Debieuvre D, Molinier O, Moro-Sibilot D, Souquet PJ, Jacquot S, Petit L, Lena H, Pignon JP, Lacas B, Morin F, Milleron B, Zalcman G, Soria JC; Intergroupe Francophone de Cancérologie Thoracique (IFCT)
Journal / Conference: Annals of Oncology
Année / Year: 2017
PMID: 28327934
Lien vers la publication: https://www.ncbi.nlm.nih.gov/pubmed/28327934
PDF: Pazo.Adj.AO.03.2017.pdf